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Abstract: Target population High-risk newborns in the context of these guidelines are children who
were born very preterm (before 32 weeks gestational age) or children who developed a ypoxic ischaemic
encephalopathy (Sarnat grade 2–3) during the first hours of life.
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who	are	born	at	term	with	a	moderate	or	se-




















disorders	 can	 also	 occur	 in	 the	 absence	 of	
major	 disabilities	 in	 all	 developmental	 do-














outcomes,	 the	 prevalence	 of	 neuro	deve-
lopmental	deficits	varies	greatly	depending	on	
country	 and	 the	 sociodemographic	 back-
ground	 of	 the	 study	 populations18),	 19).	 Many	
Introduction
Target population












as	 older	 maternal	 age	 and	 higher	 rates	 of	
medically	assisted	reproductions	have	led	to	





32	 weeks)	 are	 born	 in	 Switzerland	 every	
year3).	While	the	rate	of	children	born	preterm	




tional	 health,	 educational,	 and	 social	 ser-
vices20).	 Currently,	 no	 study	 has	 examined	























velopmental	 outcome	 of	 high-risk	 newborns.	
The	aim	was	to	provide	continuous	 follow-up	
assessments	 of	 high-risk	 newborns	 across	





follow-up	 rates,	 additional	 regional	 follow-up	
centers	 (Bellinzona,	 Lugano,	 Münsterlingen,	
Winterthur,	 Fribourg,	 Bienne,	 Neuchatel	 and	
Sion)	were	integrated	into	the	network.
A	 state-of-the-art	 population-based	 online	
registry	for	high-risk	newborns	in	Switzerland	
supports	 the	 network’s	 administration	 and	
provides	a	foundation	for	its	dual	purpose	in	
research	 and	 quality	 control.	 The	most	 im-
portant	diagnoses	and	treatments	are	pros-
pectively	collected	during	the	first	perinatal	







Recommendations of the Swiss Society of Neonatology,  
the Swiss Society of Developmental Pediatrics and the Swiss 
Society of Neuropediatrics 





1) Department of Neonatology, Zurich University 
Hospital Zurich 
2) Division of Development and Growth University 
Hospital Geneva 
3) Department of Child Development University Hos-
pital Lausanne 
4) Department of Neuropediatrics University Hospital 
Berne 
5) Department of Neuropediatrics and Developmental 
Medicine University Hospital Basel 
6) Department of Neuropediatrics Cantonal Hospital 
Aarau 
7) Department of Neuropediatrics Children’s Hospital 
Lucerne, 
8) Neonatology Unit, University Hospital Geneva
9) Child Development Center, Zurich University Child-
ren’s Hospital, Zurich Switzerland. 
Keywords: very preterm, asphyxia, follow-up, neona-
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Purpose of the follow-up 
examinations of high-risk 





tools.	 This	 enables	 early	 treatment	 of	 de-
velopmental	 impairments	 and	 facilitates	
parental	 counseling18),	 23),	 24).	 By	 registering	
neuro	developmental	 outcome	 within	 the	
SwissNeoNet,	epidemiological	data	is	gathe-






specialists	 and	 child	 neurologists.	 These	
standards	were	drawn	from	biannual	structu-




fants.	 They,	 however,	 also	 respect	 regional	





of	 Swiss	 newborn	 infants	 born	 below	 32	













































vely	 collected	 in	 the	 registry	 and	 linked	 to	
neonatal	data,	which	is	collected	from	birth	
until	discharge.	In	this	way,	the	register	pro-
vides	 an	 invaluable	 tool	 for	 pinpointing	 risk	
factors	 for	 developmental	 impairment.	 Fur-
thermore,	 the	administrative	support	of	 the	
registry	 can	 aid	 follow-up	 recruitment	 and	
organization,	which	 increases	 the	 follow-up	
rate,	to	the	benefit	of	each	participating	cen-
ter	and	ultimately	of	the	children.
Several	 research	 studies	 from	 the	 registry	
have	 contributed	 to	 a	 better	 understanding	
of	 risk	 factors	 for	 adverse	 outcome.	 For	
example,	Schlapbach	et	al.	demonstrated	that	

























Lausanne Unité de Développement, 
Centre hospitalier Universitaire Vaudois (CHUV)
021 314 34 69
Luzern Abteilung für Neuropädiatrie, Kinderspital Luzern 041 205 31 70
Neuchâtel Département de Pédiatrie, Hôpital Neuchâtelois 032 713 34 64
St. Gallen KER-Zentrum, Zentrum für Kinderneurologie, 
Entwicklung und Rehabilitation, St. Gallen
071 243 73 32
Thurgau Entwicklungspädiatrisches Zentrum, 
Kantonsspital Münsterlingen (KSM)
071 686 21 65
Ticino Servizio di Neuropediatria, 
Ospedale Regionale di Bellinzona
091 811 91 95
Valais Service de Pédiatrie, Hôpital de Sion 027 603 42 37
Winterthur Sozialpädiatrisches Zentrum, Kantonsspital Winterthur 052 266 29 17
Zürich Abteilung Entwicklungspädiatrie, Kinderspital Zürich 044 266 82 47
Table 1: Developmental	pediatric	and	neuropediatric	units	in	Switzerland	performing	
neurodevelopmental	follow-up	of	high-risk	newborns.
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mental	 outcome	of	 extremely	preterm	born	
children	 is	 determined	 by	 major	 neonatal	
morbidities	 rather	 than	 gestational	 age	 or	





centers.	 Each	 high-risk	 newborn	 needs	 an	
individual	 invitation	 to	 a	 follow-up	 center.	







follow-up,	 the	 registry’s	 infrastructure	 pro-
vides	follow-up	units	with	a	constantly	upda-









that	 formerly	 treated	 the	 patient	 and	 can	
perform	the	formal	transfer.	In	each	case,	the	
registry	 itself	 does	 not	 obtain	 any	 personal	
information	other	than	the	birth	date	and	the	
birth	location,	from	which	it	cannot	derive	any	



















portant	 to	state	 that	 the	 registry’s	first	and	
foremost	goal	is	to	facilitate	follow-up	assess-





newborns	 as	 discussed	 above.	None	of	 the	
children	are	recruited	simply	or	primarily	for	
the	purpose	of	delivering	data	to	the	registry.




lized	 and	 experienced	 in	 developmental	 as-
sessments	 and	 use	 validated	 and	 standar-
dized	tests	and	questionnaires.	The	centers	
are	 either	 child	 development	 or	 pediatric	
neurology	 centers.	 Pediatricians	 in	 private	
practice	 can	 examine	 high-risk	 children	 for	
the	 registry	 instead	 of	 a	 center	 if	 they	 can	










Contents and milestone ages of 
follow-up examinations
The	 individual	 follow-up	 examinations	 are	
performed	at	intervals	defined	by	each	center	






personnel	 and	 the	 regional	 reimbursement	
practices	of	the	disability	insurance	company	
(IV).	At	2 and 5–6 years,	follow-up	examina-
tions	using	the	jointly	agreed	identical	assess-
ment	 batteries	 are	 uniformly	 performed	
throughout	Switzerland	to	ensure	comparabi-
lity	(Fig. 1).	According	to	Vohr	et	al.	(2003),	a	
Neonatal Data is sent to SwissNeoNet:  
SwissNeoNet provides follow-up lists and tables 
for recruitment and/or transfer to other center
3 months – 15 months
individual assessment intervals 
According to center strategy
3–4 Years
Individual assessment intervals 
According to center strategy
Bayley III 









Data is sent to SwissNeoNet: 
all years: bom < 28w GA, ASP with Samat II/III 
2000, 2006, 2013: bom < 32w GA
Data is sent to SwissNeoNet: 
all years: bom < 28w GA, ASP with Samat II/III 
2000, 2006, 2013: bom < 30w GA
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(CP),	 certainly	 all	 those	 with	 moderate	 or	





to	 guarantee	 appropriate	 treatment.	 In	 the	
case	of	a	cognitive	delay,	early	 intervention	
therapy	 should	 be	 started.	 If	 behavioral	 or	
social	interaction	problems	are	noted	during	
this	exam,	or	if	it	is	unclear	whether	a	deve-






the	 issue	of	 school	 readiness,	 among	other	
questions.	 Currently,	 this	 assessment	 mi-
lestone	 suffers	 from	 the	 difficulty	 of	 long-
term	tracking	and	high	loss	to	follow-up	asso-
ciated	 in	 part	 with	 long	 periods	 of	 lack	 of	
contact	with	the	parents.	Some	centers	may	
therefore	 assess	 the	 children	 at	 3–4	 years	
using	their	individual	assessment	protocol.	
The	test	batteries	chosen	by	the	center	repre-
sentatives	 of	 the	 SwissNeoNet	 for	 the	 two	
milestone	ages	of	2	and	5–6	years	are	stan-




At 18-24 months corrected age 
(maximum	age	range	15–29	months)










fication	 of	 cerebral	 palsy	 according	 to	
























classification	 according	 to	 SCPE	 and	 the	
gross	 motor	 function	 classification	 sys-
tem35)	
•	Motor	 examination:	 Zurcher	 Neuromotor	
Assessment38)	























logy40)	 and	 to	 international	 recommenda-
tions24).	








corrected	 age	 and	 the	 provision	 of	 contact	
information	on	partnering	institutions.	Access	
to	 the	 registry	 is	 restricted	 to	 the	attending	
physicians	and	therapists	of	the	participating	





























•	Twins/triplets	 should	 be	 invited	 simulta-
neously	if	resources	allow.
•	If	parents	refuse	assessment	or	parents	do	
not	 show	 up,	 then	 the	 pediatrician	 res-
ponsible	should	be	informed	so	that	he	or	




minations,	 they	 should	 be	 asked	 if	 they	
would	be	willing	to	fill	 in	a	parental	ques-
tionnaire	 that	would	 benefit	 the	 research	
and	quality	control	but	would	be	of	no	di-
rect	benefit	to	the	child	or	its	family.
* The currently used developmental test at 5–6 years 
of age, i.e. the K-ABC, is outdated. While its revised 
version (K-ABC II) is applied in English- and French-
speaking nations, a German version is not yet 
available. The SwissNeoNet representatives have 
therefore decided to wait until 2015 before selec-
ting a replacement assessment battery for K-ABC, 
which must be available for all three major Swiss 
languages.
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Additional information
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